Virtual Rehabilitation for Cancer Survivors

Inclusion Criteria: * 1\) Age 18 years or older * 2\) Diagnosed with breast (stage 0-III), colorectal (stage I-III), head and neck (stage I-III), or lymphoma/lymphoproliferative disorder (excluded: recurrent, refractory, progressive, received or planning to receive transplant) * 3\) Completed a primary treatment (i.e. surgery and/or radiation and/or systemic therapy of any kind) within the last 24 months * 4\) If patients received systemic therapy of a fixed duration with adjuvant/curative intent, the main part should be completed, but patients are eligible if on primary, maintenance, or other adjuvant systemic therapy (e.g. eligible while on trastuzumab, immunotherapy, rituximab, oral endocrine or targeted therapy - ie ibrutinib). Indolent non-curative lymphoma patients are eligible if they have response to systemic therapy * 5\) Communicate sufficiently in English to complete intervention and questionnaires * 6\) Willing to be randomized and participate in the intervention and attend in-person or virtual assessments * 7\) Internet access * 8\) An indication for cancer rehabilitation (WHO-DAS score \>5). Exclusion Criteria: * 1\) Impaired functional status that would preclude rehabilitation (PRFS \>3) * 2\) Indication of major depressive disorder (\> or = to 20 on PHQ-9) * 3\) Diagnosis of neurological disease or condition significantly limiting cognitive functioning, such as language or memory (e.g., Alzheimer's disease or other dementia, severe traumatic brain injury); * 4\) Currently enrolled in another personalized and supervised exercise or rehabilitation program * 5\) Conditions or current injuries which are not appropriate for distance based exercise (based on intake screening questions and as determined by physician\*. \*In cases where patient's indicate an existing higher risk condition (i.e high blood pressure, recent heart attach or unstable angina, spinal cord compression, recent deep vein thrombosis) or injury, the study team will contact the physician for medical approval and clearance to participate in the study will be required)